1. Home
  2. AKRO vs EPR Comparison

AKRO vs EPR Comparison

Compare AKRO & EPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akero Therapeutics Inc.

AKRO

Akero Therapeutics Inc.

HOLD

Current Price

$54.54

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$51.90

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKRO
EPR
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.4B
IPO Year
2019
1997

Fundamental Metrics

Financial Performance
Metric
AKRO
EPR
Price
$54.54
$51.90
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$73.56
$57.06
AVG Volume (30 Days)
1.7M
601.2K
Earning Date
11-07-2025
10-29-2025
Dividend Yield
N/A
6.86%
EPS Growth
N/A
N/A
EPS
N/A
2.29
Revenue
N/A
$707,150,000.00
Revenue This Year
N/A
$5.11
Revenue Next Year
N/A
$2.70
P/E Ratio
N/A
$22.60
Revenue Growth
N/A
3.73
52 Week Low
$21.34
$41.75
52 Week High
$58.40
$61.24

Technical Indicators

Market Signals
Indicator
AKRO
EPR
Relative Strength Index (RSI) 66.54 46.19
Support Level $54.22 $51.76
Resistance Level $54.70 $52.95
Average True Range (ATR) 0.14 0.91
MACD -0.11 0.17
Stochastic Oscillator 64.18 49.24

Price Performance

Historical Comparison
AKRO
EPR

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

Share on Social Networks: